Abstract |
In a retrospective study set in French Guiana, the efficacy and tolerance of the intramuscular treatment of cutaneous leishmaniasis (CL) with a single injection of pentamidine isethionate, at 7 mg/kg, were compared with those observed, earlier, using two such injections (given 48 h apart). Although 83.6% of the 281 patients given two injections each were cured, the single-injection protocol was generally as effective, curing 78.8% of 137 patients. The single-injection protocol was also associated with fewer adverse effects than the two-injection. In the treatment of "difficult" cases (those with satellite papules or relatively high numbers of amastigotes in their lesions), however, the two-injection protocol appeared significantly more effective than the single-injection. In French Guiana, therefore, patients with CL should be given one injection with pentamidine isethionate and only be given a second, 48 h later, if they have satellite papules and/or relatively high numbers of amastigotes in their lesions.
|
Authors | M Roussel, M Nacher, G Frémont, B Rotureau, E Clyti, D Sainte-Marie, B Carme, R Pradinaud, P Couppié |
Journal | Annals of tropical medicine and parasitology
(Ann Trop Med Parasitol)
Vol. 100
Issue 4
Pg. 307-14
(Jun 2006)
ISSN: 0003-4983 [Print] England |
PMID | 16762111
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Antiprotozoal Agents
- Pentamidine
|
Topics |
- Adult
- Antiprotozoal Agents
(administration & dosage, adverse effects)
- Drug Administration Schedule
- Female
- French Guiana
(epidemiology)
- Humans
- Injections, Intramuscular
- Leishmaniasis, Cutaneous
(drug therapy, epidemiology)
- Male
- Pentamidine
(administration & dosage, adverse effects)
- Retrospective Studies
- Treatment Outcome
|